Delayed Chemo After Surgery Still Beneficial in Lung Cancer
Patient recovery may mean longer time to chemotherapy, but treatment can still have benefit
2000 to 2011 Saw Shift in Treatment for Advanced NSCLC
Rise in use of pemetrexed, erlotinib, bevacizumab; longest treatment duration with these agents
Respiratory Muscle Strength Can Predict Survival in ALS
Twitch trans-diaphragmatic pressure is most powerful biomarker for mortality stratification
Cancer Mortality Rates Continue to Decline in the United States
Researchers credit declines in smoking, better detection and treatment
New Model IDs Inflammatory Asthma Without Sputum
Combo of clinical parameters, activation of blood granulocytes can identify eosinophilic asthma
Greater Drop in Readmissions With ACA Program Penalties
Greater reductions in readmission rates compared with those at non-penalized hospitals
Alcohol Abuse Ups Risk of Several Heart Conditions
Alcohol abuse of similar magnitude to other well-recognized modifiable risk factors
December 2016 Briefing – Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for December 2016. This roundup includes the latest...
Bundled Payment Initiative Had No Effect on COPD Readmissions
Multidisciplinary care/transition intervention didn't reduce readmissions or achieve substantial savings
Age-Adjusted Cut-Offs in D-Dimer Testing for PE Cause Concern
D-dimer unit type should be clarified; specific assays that have been adequately assessed should be used
